Skip to main content

Table 3 Determinants of peak VO2, SBP, DBP, MAP, CP, ECP, and VO2/SBP (multivariable regression)

From: Determinants of exercise peak arterial blood pressure, circulatory power, and exercise cardiac power in a population based sample of Finnish male and female aged 30 to 47 years: the Cardiovascular Risk in Young Finns Study

Parameter VO2, SBP DBP MAP CPSBP CPMAP ECPWasserman ECPKoch ECPJones VO2/SBP
  β ± SE β ± SE β ± SE β ± SE β ± SE β ± SE β ± SE β ± SE β ± SE β ± SE
Sex 675 ± 77.5‡ 18.4 ± 3.6‡ 4.3 ± 2.1* 9.1 ± 2.2‡ 2300 ± 235‡ 1370 ± 140‡ 237 ± 764 1770 ± 764* 2080 ± 753† 2.4 ± 0.4‡
Age −5.5 ± 4.5 0.8 ± 0.2‡ 0.5 ± 0.1‡ 0.6 ± 0.1‡ 10.2 ± 13.6 10.2 ± 8.1 238 ± 44.3‡ 153 ± 44.3‡ 193 ± 43.7‡ −0.07 ± 0.03†
Height 23.6 ± 3.9‡ −0.12 ± 0.18 −0.26 ± 0.11* −0.23 ± 0.1* 53.7 ± 11.9‡ 24.2 ± 7.2‡ 168 ± 38.6‡ 117 ± 38.6† −189 ± 38.0‡ 0.12 ± 0.02‡
Weight 10.9 ± 2.2‡ 0.42 ± 0.1‡ 0.13 ± 0.06* 0.21 ± 0.06† −29.4 ± 6.6‡ −21.0 ± 4.0‡ −59.7 ± 21.3‡ −46.5 ± 21.3* 136 ± 21.0‡ 0.03 ± 0.01*
WHR 32.3 ± 460 28.9 ± 21.4 9.3 ± 12.6 17.2 ± 13.4 −92 ± 1390 531 ± 836 1730 ± 4530 3100 ± 4530 4120 ± 4480 −0.80 ± 2.6
PAI 78.5 ± 11.6‡ 0.86 ± 0.54 −0.25 ± 0.32 0.07 ± 0.34 224 ± 35.1‡ 118 ± 21.0‡ 720 ± 114‡ 746 ± 114‡ 708 ± 112‡ 0.34 ± 0.07‡
Smoking −228 ± 63.2‡ 0.41 ± 2.9 0.52 ± 1.7 0.48 ± 1.8 −619 ± 192† −389 ± 114‡ −1790 ± 623† −1870 ± 623‡ −1710 ± 614* −1.1 ± 0.36†
Fasting insulin −9.3 ± 3.1‡ 0.26 ± 0.15 0.19 ± 0.1 0.25 ± 0.10* −17.9 ± 9.5 −11.4 ± 6.5 −49.0 ± 30.8 −53.1 ± 30.8 −53.0 ± 30.3 −0.05 ± 0.02†
Fasting glucose 26.8 ± 39.6 −1.1 ± 1.8 −2.0 ± 1.1 −1.9 ± 1.2 158 ± 120 48.9 ± 72.9 381 ± 390 266 ± 390 243 ± 385 0.12 ± 0.23
AHT −53.6 ± 96.8 2.4 ± 4.5 5.2 ± 2.6* 4.4 ± 2.8 −54.2 ± 294 9.6 ± 175 −327 ± 954 −114 ± 954 −486 ± 940 −0.39 ± 0.56
Whole Model R2 67% 36% 13% 26% 52% 49% 21% 21% 28% 49%
  1. VO2: oxygen consumption; SBP: systolic blood pressure; DBP: diastolic blood pressure; MAP: mean arterial pressure; CP circulatory power, ECP: exercise cardiac power; WHR: waist-to-hip ratio; PAI: physical activity index; AHT: antihypertensive treatment; β: regression coefficient for a 1-unit change in parameter; SE: standard error. CP is given as a product of VO2 and SBP (CPSBP) as well as a product of VO2 and MAP (CPMAP). ECP is presented using the alternative VO2 reference value equations provided by Wasserman et al. [26], Koch et al. [25], and Jones et al. [24] and indexed correspondingly in the table as ECPWasserman, ECPKoch, and ECPJones.
  2. *p < 0.05; †p < 0.005, and ‡p < 0.001.